| 5,7-Dihydroxytryptamine | |
|---|---|
|
3-(2-aminoethyl)-1H-indole-5,7-diol |
|
|
Other names
5,7-Dihydroxytryptamine |
|
| Identifiers | |
| CAS number | 31363-74-3 |
| PubChem | 35781 |
| ChemSpider | 32913 |
| ChEMBL | CHEMBL26726 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C10H12N2O2 |
| Molar mass | 192.214 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
5,7-Dihydroxytryptamine (5,7-DHT) is a purported neurotoxin[1][2] used in scientific research to decrease concentrations of serotonin in the brain. The mechanism behind this effect isn't well-understood, but many believe (without clear substantiation) that it selectively kills serotonergic neurons, in a similar way that 6-hydroxydopamine (6-OHDA) is used to kill dopaminergic cells. What is known is that this compound is in fact not selective in depleting serotonin content, but also depletes norepinephrine. To selectively deplete serotonin stores, it is commonly administered in conjunction with desmethylimiprimine (Desipramine), which inhibits the norepinephrine transporter.
|
||||||||||||||||||||||||||||
|
|||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)